The government is planning to assist hospitals and doctors who provide care for uninsured patients with COVID-19. The department of Health and Human Services will offer Medicare rates when bills are submitted. Uninsured individuals will not be responsible for costs. (AP News)
Biogen will submit Alzheimer’s drug for Food and Drug Administration approval in Q3 after setbacks due to the coronavirus pandemic. The drugmaker originally planned to submit approval for its experimental therapy aducanumab in early 2020. (Bloomberg)
Most children diagnosed with coronavirus recover within two weeks, according to a study by JAMA Pediatrics. Those ages 19 and younger tend to develop mild symptoms such as a fever, drug cough and fatigue. (CNBC)
The World Health Organization urges caution as the pandemic is just now picking up speed in places such as Africa and central and South America. WHO director general Tedros Adhanom Ghebreyesus notes that other countries are also experiencing resurgences after seeing an initial decline in coronavirus cases. (Reuters)
The final deadline for 2020 MM&M Awards submission is Wednesday, April 29. A late fee of $235 will be applied to these entries. (MM&M)
